Article
Alpha 1-antitrypsin deficiency, complement activation, and chronic liver disease.
Journal of clinical pathology - 1 Oct 1991
Littleton E T, Bevis L, Hansen L J, Peakman M, Mowat A P, Mieli-Vergani G, Vergani D
Abstract excerpt
Activation of the complement system, the main humoral mediator of inflammation, is restrained by the action of enzyme inhibitors including alpha 1-antitrypsin. Deficiency leads to chronic liver disease in about one in five children with this genetic defect. Complement activation was investigated in 34 children with alpha 1 AT deficiency (12 with minimal, 10 with moderate, and 12 with severe liver disease) and in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
